Side-by-side comparison of AI visibility scores, market position, and capabilities
Berlin European insurtech B2B2C platform at €800M revenue with 2M+ customers; €170M Searchlight Capital refinancing Jan 2025 after $4.5B→<$1B valuation decline with new CEO Joachim Müller (ex-Allianz) competing with Clark.
Wefox is a Berlin, Germany-based European insurtech platform — having raised $1.9 billion in total funding including a $400 million Series D in 2022 at a peak $4.5 billion valuation — operating a B2B2C insurance distribution model through a network of independent insurance brokers and advisors serving over 2 million customers across the Netherlands, Austria, Switzerland, and other European markets with €800 million in annual revenue. Founded in 2014 by Julian Teicke, Fabian Wesemann, and Dario Fazlic as FinanceFox (rebranded to Wefox in 2017 after acquiring ONE Insurance), the company positioned itself as the leading European insurtech unicorn with household, motor, personal liability, health, and life insurance products. Following financial losses and valuation decline below $1 billion, founder Julian Teicke stepped down as CEO in March 2024 after nine years. In September 2024, Joachim Müller — former CEO of Allianz Global Corporate & Specialty — was appointed CEO to lead restructuring and growth. In January 2025, Wefox secured €170 million in refinancing led by Searchlight Capital Partners, exited the German and Polish markets, and focused on profitable core markets.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.